SightfileU.S. market data from official filings

ELECTROCORE INC (ECOR)

Name: ELECTROCORE INC (ECOR) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001560258 · EDGAR filings · Updated 2026-07-20

ELECTROCORE INC (ECOR) has reported institutional ownership of 10.0%, with 30 institutional managers holding positions valued at $4.90M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

10.0%

Institutional managers

Reported 13F value

$4.90M

Insider activity

20 trans.

$106.8K net buying

Data flags

2 active

from SEC filings

Latest updates

2026-07-20 — Proxy statement (DEF 14A) filed
2026-06-12 — Insider transaction reported (Form 4)
2026-05-29 — Insider transaction reported (Form 4)
2026-05-27 — Notice of proposed sale filed (Form 144)
2026-05-27 — Notice of proposed sale filed (Form 144)
2026-05-26 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ELECTROCORE INC has 30 institutional holders and institutional ownership of 10.0%.

Insider activity

Insiders reported 20 transactions (5 buys, 2 sells) across 9 reporting insiders, with a net reported value of $106.8K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-06 (recurring since 2020-03-30) — source filing. The authoritative details are those stated in the filing itself.

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2023-02-23 (recurring since 2021-12-23) — source filing. The authoritative details are those stated in the filing itself.

Related companies

MINDWALK HOLDINGS CORP COM (HYFT) · Marker Therapeutics Inc (MRKR) · CUE BIOPHARMA (CUE) · SPECTRAL AI INC (MDAI) · NASUS PHARMA LTD (NSRX) · XBiotech Inc (XBIT)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-20.